Robert Califf, FDA commissioner (Tom Williams/CQ Roll Call via AP Images)
FDA Commissioner Robert Califf highlights need for ‘creative approaches’ for rare disease therapies
The FDA’s top officials continue to call for new ways to regulate up-and-coming medicines for rare and ultra-rare diseases.
“We’re about to see a tsunami …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
